DBG(SZ:300735)2022-04-24 16:00Financial Performance - The company reported a total revenue of 772.22 million RMB for the year 2021, marking a significant increase compared to the previous year[6]. - The company's operating revenue for 2021 was ¥3,603,618,375.28, representing a 57.68% increase compared to ¥2,285,413,345.46 in 2020[24]. - The net profit attributable to shareholders for 2021 was ¥352,538,235.41, a 10.62% increase from ¥318,693,050.44 in 2020[24]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥284,944,739.22, up 5.18% from ¥270,906,233.10 in 2020[24]. - The company achieved a revenue of CNY 3.60 billion in 2021, representing a year-on-year growth of 57.68%[50]. - Net profit attributable to shareholders reached CNY 353 million, an increase of 10.62% compared to the previous year[50]. - The EMS manufacturing segment contributed CNY 3.59 billion, accounting for 99.74% of total revenue, with a growth of 58.47% year-on-year[50]. - Future performance guidance indicates a positive outlook, with expectations for continued revenue growth in the upcoming fiscal year[6]. Profit Distribution and Cash Flow - The profit distribution plan approved by the board includes a cash dividend of 2.00 RMB per 10 shares, totaling approximately 154.44 million RMB[6]. - The net cash flow from operating activities for 2021 was -¥26,267,306.04, a significant decrease of 104.83% compared to ¥543,462,608.44 in 2020[24]. - The total cash inflow from operating activities was 3,020,402,787.82 yuan, a year-on-year increase of 10.48%[102]. - The total cash outflow from operating activities was 3,046,670,093.86 yuan, reflecting a significant increase of 39.09% compared to the previous year[102]. Market Expansion and Strategic Initiatives - The company plans to expand its market presence and enhance its product offerings through ongoing research and development initiatives[6]. - The company is actively pursuing partnerships to facilitate market expansion and enhance its product distribution channels[6]. - The company is committed to exploring strategic acquisitions to bolster its competitive position in the market[6]. - The company is expanding its global footprint with acquisitions, including a controlling stake in an Indian subsidiary, and plans to establish new manufacturing bases in Vietnam and Bangladesh[42]. - The company plans to deepen its global layout and gradually expand its high-end customer base, particularly in the medical electronics market[134]. Research and Development - The company has a total of 85 patents and 12 software copyrights, reflecting its commitment to innovation and cost leadership in the industry[45]. - The company's research and development expenses increased by 13.67% to ¥100,380,142.63, primarily due to increased R&D investment[64]. - The number of R&D personnel increased by 12.24% to 1,265, accounting for 14.42% of the total workforce[101]. - The company has invested 50 million RMB in research and development to drive innovation and improve product quality[166]. Operational Efficiency and Technology - The company aims to leverage its technological advancements to improve operational efficiency and drive future growth[6]. - The company has implemented a "make-to-order" procurement model, ensuring materials are purchased based on production needs, with a strict supplier management system in place[42]. - The production model is "make-to-sell," allowing for efficient production scheduling based on customer orders, with quality control checkpoints throughout the manufacturing process[42]. - The company has focused on automation in production, reducing reliance on manual labor and improving production stability and efficiency[72]. - The integration of ERP and MES systems has facilitated seamless data transmission and improved production transparency, enhancing overall operational efficiency[83]. Governance and Management - The board of directors has emphasized the importance of maintaining transparency and accuracy in financial reporting to uphold investor confidence[6]. - The company has a governance structure that does not involve any differential voting rights arrangements[151]. - The company has implemented stock incentive plans, resulting in share increases for several executives, including 150,000 shares for Vice President Li Zhengda[154]. - The company has not faced any penalties from securities regulatory authorities in the past three years[182]. Customer and Market Insights - User data indicates a growing customer base, with an increase of 20% in active users compared to the previous year, reaching 500,000 users[166]. - The company is focusing on enhancing customer service, aiming to improve customer satisfaction scores by 15% through new training programs[166]. Future Outlook - The company has provided a positive outlook for the next fiscal year, projecting a revenue growth of 10% to 1.32 billion RMB[166]. - New product development is underway, with plans to launch three innovative products in the next quarter, targeting a market share increase of 5%[166].